These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 27577074)
1. IκB-Kinase-epsilon (IKKε) over-expression promotes the growth of prostate cancer through the C/EBP-β dependent activation of IL-6 gene expression. Péant B; Gilbert S; Le Page C; Poisson A; L'Ecuyer E; Boudhraa Z; Bienz MN; Delvoye N; Saad F; Mes-Masson AM Oncotarget; 2017 Feb; 8(9):14487-14501. PubMed ID: 27577074 [TBL] [Abstract][Full Text] [Related]
2. Over-expression of IkappaB-kinase-epsilon (IKKepsilon/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines. Péant B; Diallo JS; Dufour F; Le Page C; Delvoye N; Saad F; Mes-Masson AM Prostate; 2009 May; 69(7):706-18. PubMed ID: 19170126 [TBL] [Abstract][Full Text] [Related]
3. Regulation of IkappaB kinase epsilon expression by the androgen receptor and the nuclear factor-kappaB transcription factor in prostate cancer. Péant B; Diallo JS; Lessard L; Delvoye N; Le Page C; Saad F; Mes-Masson AM Mol Cancer Res; 2007 Jan; 5(1):87-94. PubMed ID: 17259348 [TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Zerbini LF; Wang Y; Cho JY; Libermann TA Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841 [TBL] [Abstract][Full Text] [Related]
5. Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells. Eddy SF; Guo S; Demicco EG; Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Sonenshein GE Cancer Res; 2005 Dec; 65(24):11375-83. PubMed ID: 16357145 [TBL] [Abstract][Full Text] [Related]
6. IκB-Kinase-ε (IKKε/IKKi/IκBKε) expression and localization in prostate cancer tissues. Péant B; Forest V; Trudeau V; Latour M; Mes-Masson AM; Saad F Prostate; 2011 Jul; 71(10):1131-8. PubMed ID: 21271611 [TBL] [Abstract][Full Text] [Related]
7. Co-operative functions between nuclear factors NFkappaB and CCAT/enhancer-binding protein-beta (C/EBP-beta) regulate the IL-6 promoter in autocrine human prostate cancer cells. Xiao W; Hodge DR; Wang L; Yang X; Zhang X; Farrar WL Prostate; 2004 Dec; 61(4):354-70. PubMed ID: 15389813 [TBL] [Abstract][Full Text] [Related]
8. Induction of neutrophil gelatinase-associated lipocalin expression by co-stimulation with interleukin-17 and tumor necrosis factor-alpha is controlled by IkappaB-zeta but neither by C/EBP-beta nor C/EBP-delta. Karlsen JR; Borregaard N; Cowland JB J Biol Chem; 2010 May; 285(19):14088-100. PubMed ID: 20220144 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers. Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134 [TBL] [Abstract][Full Text] [Related]
10. Alpha-tomatine attenuation of in vivo growth of subcutaneous and orthotopic xenograft tumors of human prostate carcinoma PC-3 cells is accompanied by inactivation of nuclear factor-kappa B signaling. Lee ST; Wong PF; He H; Hooper JD; Mustafa MR PLoS One; 2013; 8(2):e57708. PubMed ID: 23437404 [TBL] [Abstract][Full Text] [Related]
11. Translationally regulated C/EBP beta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells. Kim MH; Fields J Prostate; 2008 Sep; 68(12):1362-71. PubMed ID: 18512730 [TBL] [Abstract][Full Text] [Related]
12. CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells. Barakat DJ; Zhang J; Barberi T; Denmeade SR; Friedman AD; Paz-Priel I Oncogene; 2015 Nov; 34(48):5912-22. PubMed ID: 25772238 [TBL] [Abstract][Full Text] [Related]
13. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells. Sanford DC; DeWille JW Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993 [TBL] [Abstract][Full Text] [Related]
14. C/EBPbeta regulates metastatic gene expression and confers TNF-alpha resistance to prostate cancer cells. Kim MH; Minton AZ; Agrawal V Prostate; 2009 Sep; 69(13):1435-47. PubMed ID: 19489038 [TBL] [Abstract][Full Text] [Related]
15. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells. Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933 [TBL] [Abstract][Full Text] [Related]
16. Inducible gene expression of IκB-kinase ε is dependent on nuclear factor-κB in human pulmonary epithelial cells. Necker-Brown A; Kooi C; Thorne AJ; Bansal A; Mostafa MM; Chandramohan P; Gao A; Kalyanaraman K; Milani A; Gill S; Georgescu A; Sasse SK; Gerber AN; Leigh R; Newton R Biochem J; 2024 Jul; 481(14):959-980. PubMed ID: 38941070 [TBL] [Abstract][Full Text] [Related]
17. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells. Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161 [TBL] [Abstract][Full Text] [Related]
18. Targeting IKKε in Androgen-Independent Prostate Cancer Causes Phenotypic Senescence and Genomic Instability. Gilbert S; Péant B; Malaquin N; Tu V; Fleury H; Leclerc-Desaulniers K; Rodier F; Mes-Masson AM; Saad F Mol Cancer Ther; 2022 Mar; 21(3):407-418. PubMed ID: 34965959 [TBL] [Abstract][Full Text] [Related]
19. Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA. Zhang Y; Lapidus RG; Liu P; Choi EY; Adediran S; Hussain A; Wang X; Liu X; Dan HC Mol Cancer Ther; 2016 Jul; 15(7):1504-14. PubMed ID: 27196761 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha-induced apoptosis in prostate cancer cells through inhibition of nuclear factor-kappaB by an IkappaBalpha "super-repressor". Muenchen HJ; Lin DL; Walsh MA; Keller ET; Pienta KJ Clin Cancer Res; 2000 May; 6(5):1969-77. PubMed ID: 10815922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]